ArticleBlood cancer journal2024

Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma.

Bachisio Ziccheddu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.